150 related articles for article (PubMed ID: 30527382)
1. Experience with 5% ethanolamine oleate for sclerotherapy of oral vascular anomalies: A cohort of 15 consecutive patients.
Kato CNAO; Ribeiro MC; do Amaral MBF; Grossmann SMC; de Aguiar MCF; Mesquita RA
J Craniomaxillofac Surg; 2019 Jan; 47(1):106-111. PubMed ID: 30527382
[TBL] [Abstract][Full Text] [Related]
2. What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?
Kato CN; Ribeiro MC; Abreu MH; Grossmann SD; Abreu LG; Caldeira PC; Mesquita RA
Med Oral Patol Oral Cir Bucal; 2020 Jul; 25(4):e468-e473. PubMed ID: 32388528
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of foam sclerotherapy with 5% ethanolamine oleate in the treatment of low-flow venous malformations in the head and neck region: a case series.
Ribeiro MC; de Mattos Camargo Grossmann S; do Amaral MBF; de Castro WH; Navarro TP; Procopio RJ; da Silva TA; de Nazaré Alves de Oliveira Kato C; Mesquita RA
Int J Oral Maxillofac Surg; 2018 Jul; 47(7):900-907. PubMed ID: 29329829
[TBL] [Abstract][Full Text] [Related]
4. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions.
Johann AC; Aguiar MC; do Carmo MA; Gomez RS; Castro WH; Mesquita RA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Nov; 100(5):579-84. PubMed ID: 16243243
[TBL] [Abstract][Full Text] [Related]
5. Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.
Kitagawa A; Izumi Y; Hagihara M; Kamei S; Ikeda S; Katsuda E; Kimura J; Ota T; Ishiguchi T
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):371-80. PubMed ID: 23737022
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):695-8. PubMed ID: 24235099
[TBL] [Abstract][Full Text] [Related]
7. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy.
Hyodoh H; Fujita A; Hyodoh K; Furuse M; Kamisawa O; Hareyama M
Cardiovasc Intervent Radiol; 2001; 24(5):348-51. PubMed ID: 11815844
[TBL] [Abstract][Full Text] [Related]
8. Effects of blood flow control on clinical outcomes after ethanolamine oleate sclerotherapy for vascular malformations.
Hyodoh H; Akiba H; Hyodoh K; Ezoe K; Yotsuyanagi T; Hareyama M
Jpn J Radiol; 2009 Oct; 27(8):297-302. PubMed ID: 19856224
[TBL] [Abstract][Full Text] [Related]
9. Venous malformation of the tongue in a child treated by sclerotherapy with ethanolamine oleate: a case report.
Nishikawa M; Sakamoto K; Hidaka M; Yamashita A; Yamamoto G
J Pediatr Surg; 2006 Mar; 41(3):599-600. PubMed ID: 16516646
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336
[TBL] [Abstract][Full Text] [Related]
11. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck.
Kaji N; Kurita M; Ozaki M; Takushima A; Harii K; Narushima M; Wakita S
Scand J Plast Reconstr Surg Hand Surg; 2009; 43(3):126-36. PubMed ID: 19401940
[TBL] [Abstract][Full Text] [Related]
12. Treatment of venous malformations with ethanolamine oleate.
Das BK; Hoque S
Asian J Surg; 2008 Oct; 31(4):220-4. PubMed ID: 19010768
[TBL] [Abstract][Full Text] [Related]
13. Arteriovenous malformations: ethanolamine oleate sclerotherapy.
Hyodoh H; Hyodoh K
Acta Chir Iugosl; 2007; 54(3):81-6. PubMed ID: 17988037
[TBL] [Abstract][Full Text] [Related]
14. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy.
Hong SK; Lee HJ; Seo JK; Lee D; Hwang SW; Sung HS
Dermatol Surg; 2010 Jul; 36(7):1148-52. PubMed ID: 20533938
[TBL] [Abstract][Full Text] [Related]
15. Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate: A retrospective study of 43 patients.
Fernandes DT; Elias RA; Santos-Silva AR; Vargas PA; Lopes MA
Med Oral Patol Oral Cir Bucal; 2018 Mar; 23(2):e180-e187. PubMed ID: 29476682
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases.
Hoque S; Das BK
Pediatr Surg Int; 2011 May; 27(5):527-31. PubMed ID: 21290138
[TBL] [Abstract][Full Text] [Related]
17. Complete eradication of duodenal varices after endoscopic injection sclerotherapy with ethanolamine oleate: a case report.
Seo YS; Kwon YD; Park S; Keum B; Park BJ; Kim YS; Jeen YT; Chun HJ; Kim CD; Ryu HS; Um SH
Gastrointest Endosc; 2008 Apr; 67(4):759-62. PubMed ID: 18206152
[No Abstract] [Full Text] [Related]
18. [Specific indications for foam sclerotherapy].
Kahle B
Hautarzt; 2017 Aug; 68(8):621-624. PubMed ID: 28577056
[TBL] [Abstract][Full Text] [Related]
19. Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience.
Yamamoto K; Sakaguchi H; Anai H; Tanaka T; Morimoto K; Kichikawa K; Uchida H
Cardiovasc Intervent Radiol; 2005; 28(6):751-5. PubMed ID: 16132390
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations.
Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A
Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
